Optimind Pharma Corp. (CSE:OMND)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
+0.0050 (100.00%)
Jul 2, 2025, 11:32 AM EDT
100.00%
Market Cap1.03M
Revenue (ttm)118.37K
Net Income (ttm)-215.81K
Shares Out102.79M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,108
Average Volume2,255
Open0.0050
Previous Close0.0050
Day's Range0.0050 - 0.0100
52-Week Range0.0050 - 0.0100
Beta0.16
RSI53.32
Earnings DateJun 27, 2025

About Optimind Pharma

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada. [Read more]

Sector Healthcare
CEO David Goodman
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol OMND
Full Company Profile

Financial Performance

In 2024, Optimind Pharma's revenue was 118,368, a decrease of -3.73% compared to the previous year's 122,959. Losses were -215,812, -84.56% less than in 2023.

Financial Statements

News

There is no news available yet.